Skip to main content
SpringerLink
Log in

Natriuretic Peptide Guided Therapy in Outpatient Heart Failure Management

  • Chapter
  • First Online:
Cardiac Biomarkers

Abstract

An increased focus on precision outpatient heart failure management has the potential to decrease the significant morbidity, mortality and cost associated with heart failure hospitalization. Natriuretic peptides represent an objective and reproducible surrogate measurement of cardiac function and volume status which is widely available in the ambulatory setting. Initial trials using natriuretic peptides to guide therapy in ambulatory heart failure patients have shown promise in decreasing associated morbidity and mortality, however, have been limited by significant inter-study variability in inclusion criteria, threshold natriuretic peptide levels and implementation of therapeutic intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Felker GM, Ahmad T, Anstrom KJ, et al. Rationale and design of the GUIDE-IT study: guiding evidence based therapy using biomarker intensified treatment in heart failure. JACC Heart Fail. 2014;2(5):457–65. doi:10.1016/j.jchf.2014.05.007.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet (London, England). 2000;355(9210):1126–1130. http://www.ncbi.nlm.nih.gov/pubmed/10791374. Accessed December 27, 2015.

    Google Scholar 

  3. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol. 2007;49(16):1733–9. doi:10.1016/j.jacc.2006.10.081.

    Article  CAS  PubMed  Google Scholar 

  4. Pfisterer M, Buser P, Rickli H, et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA. 2009;301(4):383–92. doi:10.1001/jama.2009.2.

    Article  CAS  PubMed  Google Scholar 

  5. Persson H, Erntell H, Eriksson B, Johansson G, Swedberg K, Dahlström U. Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure–SIGNAL-HF (Swedish Intervention study–Guidelines and NT-proBNP AnaLysis in Heart Failure). Eur J Heart Fail. 2010;12(12):1300–8. doi:10.1093/eurjhf/hfq169.

    Article  CAS  PubMed  Google Scholar 

  6. Karlström P, Alehagen U, Boman K, Dahlström U. Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome. Eur J Heart Fail. 2011;13(10):1096–103. doi:10.1093/eurjhf/hfr078.

    Article  PubMed  Google Scholar 

  7. Januzzi JL, Rehman SU, Mohammed AA, et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol. 2011;58(18):1881–9. doi:10.1016/j.jacc.2011.03.072.

    Article  CAS  PubMed  Google Scholar 

  8. Lainchbury JG, Troughton RW, Strangman KM, et al. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol. 2009;55(1):53–60. doi:10.1016/j.jacc.2009.02.095.

    Article  PubMed  Google Scholar 

  9. Berger R, Moertl D, Peter S, et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol. 2010;55(7):645–53. doi:10.1016/j.jacc.2009.08.078.

    Article  CAS  PubMed  Google Scholar 

  10. Shah MR, Califf RM, Nohria A, et al. The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure. J Card Fail. 2011;17(8):613–21. doi:10.1016/j.cardfail.2011.04.012.

    Article  PubMed  Google Scholar 

  11. Eurlings LWM, van Pol PEJ, Kok WE, et al. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol. 2010;56(25):2090–100. doi:10.1016/j.jacc.2010.07.030.

    Article  CAS  PubMed  Google Scholar 

  12. Felker GM, Hasselblad V, Hernandez AF, O’Connor CM. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J. 2009;158(3):422–30. doi:10.1016/j.ahj.2009.06.018.

    Article  CAS  PubMed  Google Scholar 

  13. Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H. B-type natriuretic peptide-guided heart failure therapy: a meta-analysis. Arch Intern Med. 2010;170(6):507–14. doi:10.1001/archinternmed.2010.35.

    Article  CAS  PubMed  Google Scholar 

  14. Savarese G, Trimarco B, Dellegrottaglie S, et al. Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials. PLoS One. 2013;8(3), e58287. doi:10.1371/journal.pone.0058287.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Troughton RW, Frampton CM, Brunner-La Rocca H-P, et al. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. Eur Heart J. 2014;35(23):1559–67. doi:10.1093/eurheartj/ehu090.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Schou M, Gislason G, Videbaek L, et al. Effect of extended follow-up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study. Eur J Heart Fail. 2014;16(11):1249–55. doi:10.1002/ejhf.176.

    Article  CAS  PubMed  Google Scholar 

  17. Pascual-Figal DA, Domingo M, Casas T, et al. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J. 2008;29(8):1011–8. doi:10.1093/eurheartj/ehn023.

    Article  CAS  PubMed  Google Scholar 

  18. Dharmarajan K, Hsieh AF, Lin Z, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309(4):355–63. doi:10.1001/jama.2012.216476.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sanders-van Wijk S, van Asselt ADI, Rickli H, et al. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). JACC Heart Fail. 2013;1(1):64–71. doi:10.1016/j.jchf.2012.08.002.

    Article  PubMed  Google Scholar 

  20. Sanders-van Wijk S, Maeder MT, Nietlispach F, et al. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Circ Heart Fail. 2014;7(1):131–9. doi:10.1161/CIRCHEARTFAILURE.113.000527.

    Article  CAS  PubMed  Google Scholar 

  21. Maisel A, Barnard D, Jaski B, et al. Primary results of the HABIT Trial (heart failure assessment with BNP in the home). J Am Coll Cardiol. 2013;61(16):1726–35. doi:10.1016/j.jacc.2013.01.052.

    Article  PubMed  Google Scholar 

  22. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with t. Circulation. 2009;119(14):1977–2016. doi:10.1161/CIRCULATIONAHA.109.192064.

    Article  PubMed  Google Scholar 

  23. McMurray JJV, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart. Eur Heart J. 2012;33(14):1787–847. doi:10.1093/eurheartj/ehs104.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, University of Maryland Medical Center, Baltimore, MD, USA

    Matthew N. Peters MD

  2. Department of Medicine, University of Maryland School of Medicine, Maryland Heart Center University of Maryland Medical Center, Baltimore, MD, USA

    Christopher R. deFilippi MD

Authors
  1. Matthew N. Peters MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher R. deFilippi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew N. Peters MD .

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Medicine, University of California San Diego Division of Cardiovascular Medicine, La Jolla, California, USA

    Alan S. Maisel

  2. Cardiology Department, Mayo Clinic Cardiology Department, ROCHESTER, Minnesota, USA

    Allan S. Jaffe

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Peters, M.N., deFilippi, C.R. (2016). Natriuretic Peptide Guided Therapy in Outpatient Heart Failure Management. In: Maisel, A., Jaffe, A. (eds) Cardiac Biomarkers. Springer, Cham. https://doi.org/10.1007/978-3-319-42982-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42982-3_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42980-9

  • Online ISBN: 978-3-319-42982-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation